| 000 | 01568 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518071735.0 | ||
| 264 | 0 | _c20201204 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.13072 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Xiao | |
| 245 | 0 | 0 |
_aInitial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cApr 2020 |
||
| 300 |
_a309-317 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aNonlinear Dynamics |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 700 | 1 | _aWang, Dongdong | |
| 700 | 1 | _aXu, Hong | |
| 700 | 1 | _aLi, Zhiping | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 45 _gno. 2 _gp. 309-317 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.13072 _zAvailable from publisher's website |
| 999 |
_c30340171 _d30340171 |
||